Beam Therapeutics BEAM Operating margin

Operating margin at other companies

Vertex PharmaceuticalsVRTX

38%—

Arrowhead ResearchARWR

-35.7%+63.6pp

Ultragenyx PharmaceuticalRARE

-73.6%-7.3pp

MGN

MagniteMGNI

15.6%+4.5pp

Wave Life SciencesWVE

-75.7%-33.6pp

Intellia TherapeuticsNTLA

-711.7%-149pp

FAQ

What is Beam Therapeutics's operating margin?

Beam Therapeutics (BEAM) reported operating margin of -226.6% in Q1 2026.

How has Beam Therapeutics's operating margin changed year-over-year?

Beam Therapeutics's operating margin increased by 66.6% year-over-year, from -677.5% to -226.6%.

What is the long-term trend for Beam Therapeutics's operating margin?

Over 4 years (2020 to 2025), Beam Therapeutics's operating margin has grown at a -85.1% compound annual growth rate (CAGR), from -553,166.7% to -274.6%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.